Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CNR2 | P34972 | 6/20 | 0.54 |
| ▸ | CNR1 | P21554 | 5/20 | 0.54 |
| ▸ | MEN1 | O00255 | 1/20 | 0.46 |
| ▸ | GAA | P10253 | 1/20 | 0.46 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.46 |
| ▸ | KDR | P35968 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11758555 | 1.00 | CNR2 (0.54) | CNR2CNR1MEN1GAAKMT2A | |
| SCHEMBL11737062 | 0.91 | CNR2 (0.67) | CNR2CNR1MEN1GAAKMT2A | |
| SCHEMBL29744991 | 0.91 | CNR2 (0.67) | CNR2CNR1MEN1GAAKMT2A | |
| SCHEMBL11742528 | 0.87 | CNR2 (0.44) | CNR2CNR1MEN1GAAKMT2A | |
| SCHEMBL31545118 | 0.85 | CNR2 (0.53) | CNR2CNR1MEN1GAAKMT2A | |
| SCHEMBL11794288 | 0.84 | CNR2 (0.41) | CNR2CNR1MEN1GAAKMT2A | |
| SCHEMBL11742241 | 0.84 | CNR2 (0.46) | CNR2CNR1MEN1GAAKMT2A | |
| SCHEMBL31546201 | 0.84 | CNR2 (0.46) | CNR2CNR1MEN1GAAKMT2A | |
| SCHEMBL11756571 | 0.84 | CNR2 (0.42) | CNR2CNR1MEN1GAAKMT2A | |
| SCHEMBL11734041 | 0.84 | CNR2 (0.46) | CNR2CNR1MEN1GAAKMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250090554-A1 | A METHOD OF TREATING DEPRESSION BY IMMUNE MODULATION | MYND LIFE SCIENCES INC (CA) | 2025-03-20 | — | — | US | disclosed |